131 related articles for article (PubMed ID: 8500532)
1. Inhibition of complement alternative pathway in mice with Fab antibody to recombinant adipsin/factor D.
Pascual M; Catana E; White T; Spiegelman BM; Schifferli JA
Eur J Immunol; 1993 Jun; 23(6):1389-92. PubMed ID: 8500532
[TBL] [Abstract][Full Text] [Related]
2. Adipsin and complement factor D activity: an immune-related defect in obesity.
Rosen BS; Cook KS; Yaglom J; Groves DL; Volanakis JE; Damm D; White T; Spiegelman BM
Science; 1989 Jun; 244(4911):1483-7. PubMed ID: 2734615
[TBL] [Abstract][Full Text] [Related]
3. Modest release of adipsin/factor D by liposuction when using the superwet or tumescent technique.
Samdal F; Mollnes TE; Amland PF; Truedsson L
Plast Reconstr Surg; 1997 May; 99(6):1591-4; discussion 1595-6. PubMed ID: 9145127
[TBL] [Abstract][Full Text] [Related]
4. Components of the alternative complement pathway in patients with psoriasis.
Sereflican B; Bugdayci G
Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):37-40. PubMed ID: 28632884
[TBL] [Abstract][Full Text] [Related]
5. Expression and complement d activity of porcine adipsin.
Miner JL; Hahn KJ; Spurlock ME; Staten NR
Protein Expr Purif; 2001 Oct; 23(1):14-21. PubMed ID: 11570841
[TBL] [Abstract][Full Text] [Related]
6. Dynamics and reproductive effects of complement factors in the spontaneous abortion model of CBA/J×DBA/2 mice.
Takeshita A; Kusakabe KT; Hiyama M; Kuniyoshi N; Kondo T; Kano K; Kiso Y; Okada T
Immunobiology; 2014 May; 219(5):385-91. PubMed ID: 24576554
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in factor D-deficient mice.
Xu Y; Ma M; Ippolito GC; Schroeder HW; Carroll MC; Volanakis JE
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14577-82. PubMed ID: 11724962
[TBL] [Abstract][Full Text] [Related]
9. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.
White RT; Damm D; Hancock N; Rosen BS; Lowell BB; Usher P; Flier JS; Spiegelman BM
J Biol Chem; 1992 May; 267(13):9210-3. PubMed ID: 1374388
[TBL] [Abstract][Full Text] [Related]
10. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody which blocks the function of factor D of human complement.
Pascual M; Catana E; Spertini F; Macon K; Volanakis JE; Schifferli JA
J Immunol Methods; 1990 Mar; 127(2):263-9. PubMed ID: 2313104
[TBL] [Abstract][Full Text] [Related]
12. Elevation of adipsin, a complement activating factor, in the mouse placenta during spontaneous abortion.
TAKESHITA A; KONDO T; OKADA T; KUSAKABE KT
J Reprod Dev; 2010 Oct; 56(5):508-14. PubMed ID: 20581430
[TBL] [Abstract][Full Text] [Related]
13. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
Sundsmo JS; Götze O
J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
[TBL] [Abstract][Full Text] [Related]
14. Adipsin and the glucose transporter GLUT4 traffic to the cell surface via independent pathways in adipocytes.
Millar CA; Meerloo T; Martin S; Hickson GR; Shimwell NJ; Wakelam MJ; James DE; Gould GW
Traffic; 2000 Feb; 1(2):141-51. PubMed ID: 11208094
[TBL] [Abstract][Full Text] [Related]
15. Induction of Ocular Complement Activation by Inflammatory Stimuli and Intraocular Inhibition of Complement Factor D in Animal Models.
Crowley MA; Delgado O; Will-Orrego A; Buchanan NM; Anderson K; Jaffee BD; Dryja TP; Liao SM
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):940-951. PubMed ID: 29450541
[TBL] [Abstract][Full Text] [Related]
16. Effect of cycloheximide and of anti-C3 Fab' on the intrinsic synthesis and secretion of lysosomal enzyme and of complement components by guinea-pig peritoneal macrophages.
Kreuzpaintner G; Brade V
Immunology; 1983 Jun; 49(2):337-42. PubMed ID: 6552217
[TBL] [Abstract][Full Text] [Related]
17. Adipsin and an endogenous pathway of complement from adipose cells.
Choy LN; Rosen BS; Spiegelman BM
J Biol Chem; 1992 Jun; 267(18):12736-41. PubMed ID: 1618777
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of factor D of the alternative complement pathway.
Lesavre PH; Müller-Eberhard HJ
J Exp Med; 1978 Dec; 148(6):1498-509. PubMed ID: 82604
[TBL] [Abstract][Full Text] [Related]
19. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
20. New synthetic inhibitor to the alternative complement pathway.
Ikari N; Sakai Y; Hitomi Y; Fujii S
Immunology; 1983 Aug; 49(4):685-91. PubMed ID: 6553561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
